Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Phase 1 Completed
25 enrolled 14 charts
D2C7 for Adult Patients With Recurrent Malignant Glioma
Phase 1 Completed
81 enrolled
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
Phase 1 Completed
16 enrolled
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Phase 1 Completed
12 enrolled
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Phase 1 Completed
26 enrolled
TumorGlow(TM)
Phase 1 Completed
363 enrolled
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Phase 1 Completed
17 enrolled
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Phase 1 Completed
11 enrolled
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
Phase 1 Completed
14 enrolled
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
Phase 1 Completed
21 enrolled 12 charts
Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
Phase 1 Completed
3 enrolled 12 charts
Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors
Phase 1 Completed
61 enrolled
PNOC025
Phase 1 Completed
13 enrolled
HUMC 1612: Optune NovoTTF-200A System
Phase 1 Completed
7 enrolled 12 charts
Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors
Phase 1 Completed
16 enrolled 14 charts
Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Phase 1 Completed
22 enrolled
CerebralEDV
Phase 1 Completed
9 enrolled
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Phase 1 Completed
17 enrolled 15 charts
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Phase 1 Completed
33 enrolled
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
Phase 1 Completed
17 enrolled 8 charts
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1 Completed
54 enrolled
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
Phase 1 Completed
35 enrolled
Pilot Immunotherapy Trial for Recurrent Malignant Gliomas
Phase 1 Completed
13 enrolled
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Phase 1 Completed
17 enrolled 11 charts
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Phase 1 Completed
25 enrolled
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Phase 1 Completed
97 enrolled
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Phase 1 Completed
21 enrolled
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Phase 1 Completed
21 enrolled
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
Phase 1 Completed
13 enrolled
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Phase 1 Completed
59 enrolled 20 charts
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Completed
29 enrolled
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Phase 1 Completed
11 enrolled 26 charts
Feasibility of Aromatherapy in an Awake Craniotomy Environment
Phase 1 Completed
40 enrolled 8 charts
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Phase 1 Completed
41 enrolled
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Phase 1 Completed
68 enrolled
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
Phase 1 Completed
13 enrolled
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
AflacST1501
Phase 1 Completed
53 enrolled
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
Phase 1 Completed
63 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Phase 1 Completed
230 enrolled
A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
24 enrolled
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Phase 1 Completed
22 enrolled
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Phase 1 Completed
10 enrolled
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
Phase 1 Completed
29 enrolled
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
Phase 1 Completed
27 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
Metformin in Children With Relapsed or Refractory Solid Tumors
Phase 1 Completed
26 enrolled
PerCellVac3
Phase 1 Completed
10 enrolled